The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
According to the FTC, the three largest PBMs — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — used their power to exclude cheaper insulin products from the menu of ...
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...
Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback